Mexico approves AstraZeneca's coronavirus vaccine for emergency use

Mexico approved the Oxford-AstraZeneca coronavirus vaccine for emergency use Monday, hoping to spur a halting vaccination effort that has only given about 44,000 shots since the third week of December

AstraZeneca
AstraZeneca vaccine
AP Mexico City
1 min read Last Updated : Jan 05 2021 | 9:16 AM IST

Mexico approved the Oxford-AstraZeneca coronavirus vaccine for emergency use Monday, hoping to spur a halting vaccination effort that has only given about 44,000 shots since the third week of December, about 82 per cent of the doses the country has received.

Prior to this, the Pfizer vaccine was the only one approved for use in Mexico. Mexican regulators approved the AstraZeneca shot. Assistant Health Secretariat Hugo Lpez-Gatell said he erroneously reported approval for Chinese vaccine maker CanSino, noting it had not yet submitted full study results for safety and efficacy.

Mexico has pinned much of its hopes on the inexpensive, one-shot CanSino vaccine. It will makes things a lot easier for us, Lpez-Gatell said.

Lpez-Gatell, who heads up efforts to deal with the pandemic, had to explain why he was spotted at a Pacific coast beach, apparently sitting at sea-side restaurant without a face mask on.

Lpez-Gatell has repeatedly counselled Mexicans to stay at home. He has also cast doubt on how whether face masks protect people from catching coronavirus.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :AstraZenecaMexicoCoronavirus Vaccine

First Published: Jan 05 2021 | 8:50 AM IST

Next Story